973 5 624 n-butyl acetate 123-86-4 56, 73 0 0 0 0 0 239 ethyl iso

973 5.624 n-butyl acetate 123-86-4 56, 73 0 0 0 0 0.239 ethyl isovalerate 108-64-5 70 0 0 0 < LOD 0.852 isopentyl acetate 123-92-2 55, 70 0 0 0 < LOD 1.938 ethyl

formate 109-94-4 31 0 0 0 < LOD 3.188 methyl methacrylate ** 80-62-6 - 15.99 14.79 20.27 28.65 31.93 methanethiol 74-93-1 47 134.2 210.4 360.6 559.4 701.5 dimethyldisulfide (DMDS) 624-92-0 94 1.558 2.221 3.657 8.134 10.24 1,3-butadiene 106-99-0 54 < LOD < LOD 4.941 4.342 4.313 2-methylpropene 115-11-7 56 < LOD < LOD 4.546 14.31 21.89 n-butane 106-97-8 58 0.664 0.703 1.274 2.504 4.329 (Z)-2-butene 590-18-1 56 0 0 < LOD 3.687 4.789 (E)-2-butene 624-64-6 56 1.344 < LOD 4.793 11.32 13.73 propane 74-98-6 43, 41 0.91 0.815 1.951 3.441 4.902 Bold numbers indicate significant difference (Kruskal-Wallis Veliparib mw test) in VOC concentrations between FRAX597 in vitro bacteria cultures and medium headspace (p < 0.05).

Ethanol, 2-methylpropanal, 3- methylbutanal and methyl methacrylate were analyzed in TIC mode as indicated by **, while the remaining compounds were analyzed in SIM mode. Number of Anlotinib in vitro independent experiments n = 5 for each time point of bacteria growth, n = 14 for all medium controls. Concentrations are given in ppbv, § uptake (decreased concentration). Table 3 A and B: Median concentrations of VOCs released (A) or taken up (B) by Pseudomonas aeruginosa Compound CAS m/z for SIM M [ppbv] 1.5 (n = 3) 2.25 (n = 4) 3 (n = 4) 3.75 (n = 5) 4.5 (n = 5) 5.20 (n = 4) 6 (n = 6) 24 (n = 5) 26 (n = 4) 28 (n = 3) A)                           3-methyl-1-butanol 123-51-3 55, 70 62.56 148.4

142.2 ethanol* 64-17-5 – 102.1 623.5 322.2 396.4 441.4 548.9 800.0 761.6 203.1 333.3 350.4 2-butanol# 78-92-2 45 0 0 0 0 0 0 0 0 0 1.5E + 04 8.5E + 03 2-nonanone 821-55-6 43, 56, 71 1.091 1.586 3.855 6.372 10.29 15.33 14.83 12.24 21.82 22.42 2-pentanone 107-87-9 43, 86 0.526 0.910 0.901 12.91 19.30 17.94 2-heptanone 110-43-0 43, 71 n.d. 0.286 0.259 2.700 4.789 3.622 4-heptanone 123-19-3 43, 71 n.d. n.d. n.d. n.d. n.d. 0.422 Ureohydrolase 0.496 1.000 2.079 1.088 3-octanone* 106-68-3 – n.d. n.d. n.d. n.d. n.d. n.d. n.d. 0.557 0.817 2-butanone* 78-93-3 – 10.08 25.49 23.57 15.89 17.90 17.11 19.39 14.65 30.39 40.55 40.03 methyl isobutyl ketone# 108-10-1 85, 100 3.8E + 04 8.7E + 04 8.0E + 04 5.5E + 04 7.9E + 04 6.5E + 04 7.6E + 04 6.4E + 04 2.3E + 05 3.8E + 05 2.7E + 05 ethyl acetate 141-78-6 61 1.936 1.123 0.777 1.556 1.167 1.088 1.231 1.972 2.686 1.895 methyl 2-methylbutyrate 868-57-5 56, 85 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 0.637 1.669 methyl methacrylate* 80-62-6 – 24.81 38.14 44.49 32.28 44.03 36.81 46.67 38.67 47.72 54.17 48.13 ethyl 2-methylbutyrate# 7452-79-1 57, 74, 85 0 0 0 0 0 0 0 0 7.5E + 04 1.4E + 05 1.8E + 05 2-methylbutyl isobutyrate# 2445-69-4 55, 70 0 0 0 0 0 0 0 0 5.2E + 05 1.2E + 06 1.3E + 06 isoamyl butyrate# 106-27-4 43, 71 0 0 0 0 0 0 0 0 2.5E + 05 1.4E + 06 7.6E + 05 2-methylbutyl 2-methylbutyrate# 2445-78-5 57, 70, 85 0 0 0 0 0 0 0 0 2.7E + 06 7.6E + 06 9.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>